Corient Capital Partners’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$857K Buy
18,914
+3,928
+26% +$174K 0.06% 242
2022
Q2
$679K Sell
14,986
-2,222
-13% -$104K 0.05% 288
2022
Q1
$820K Sell
17,208
-4,041
-19% -$171K 0.05% 279
2021
Q4
$875K Buy
21,249
+6,252
+42% +$235K 0.06% 244
2021
Q3
$517K Sell
14,997
-3,891
-21% -$133K 0.04% 349
2021
Q2
$597K Buy
18,888
+1,892
+11% +$60.9K 0.04% 320
2021
Q1
$530K Sell
16,996
-676
-4% -$20.3K 0.05% 306
2020
Q4
$532K Sell
17,672
-119
-0.7% -$3.51K 0.05% 263
2020
Q3
$454K Sell
17,791
-525
-3% -$13.9K 0.05% 271
2020
Q2
$474K Buy
18,316
+2,894
+19% +$76.8K 0.06% 256
2020
Q1
$405K Sell
15,422
-2,215
-13% -$69.7K 0.06% 250
2019
Q4
$574K Sell
17,637
-854
-5% -$27.6K 0.07% 259
2019
Q3
$637K Buy
18,491
+2,120
+13% +$71.2K 0.09% 222
2019
Q2
$560K Buy
16,371
+978
+6% +$34.5K 0.09% 223
2019
Q1
$551K Buy
15,393
+1,335
+9% +$45.5K 0.09% 207
2018
Q4
$452K Buy
14,058
+910
+7% +$29.1K 0.08% 215
2018
Q3
$410K Hold
13,148
0.07% 207
2018
Q2
$400K Buy
13,148
+2,327
+22% +$66.6K 0.07% 205
2018
Q1
$301K Sell
10,821
-398
-4% -$10.7K 0.06% 213
2017
Q4
$316K Hold
11,219
0.05% 227
2017
Q3
$301K Sell
11,219
-385
-3% -$10.3K 0.06% 224
2017
Q2
$299K Buy
11,604
+35
+0.3% +$891 0.05% 256
2017
Q1
$297K Sell
11,569
-2,203
-16% -$56.1K 0.05% 254
2016
Q4
$349K Sell
13,772
-1,633
-11% -$38.7K 0.06% 237
2016
Q3
$366K Buy
+15,405
New +$387K 0.07% 228

Other funds holding EXC

Corient Capital Partners's EXC Position: Q3 2022 in Review

Corient Capital Partners increased its Exelon (EXC) stake by 26% in Q3 2022, buying an estimated $174K and bringing the position to 18,914 shares worth $857K. The position accounts for 0.06% of the portfolio, ranked #242.

Corient Capital Partners first reported a position in EXC in Q3 2016 and has held it in 25 quarters since. The position peaked at $875K in Q4 2021. 988 funds tracked by Wall St. Rank hold EXC as of Q3 2022.

  • Corient Capital Partners held 18,914 shares of Exelon worth $857K as of Q3 2022.
  • Corient Capital Partners bought 3,928 Exelon shares in Q3 2022, an estimated $174K.
  • Exelon made up 0.06% of Corient Capital Partners's portfolio in Q3 2022, its #242 holding.
  • Corient Capital Partners first reported a position in Exelon in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's Exelon position peaked at $875K in Q4 2021.
  • 988 funds tracked by Wall St. Rank held Exelon as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.